Valcad Injection is indicated in the treatment and management of multiple myeloma and relapsed mantle cell lymphoma.
Detailed Description :
Generic Name: BortezomibValcad is a targeted therapy. It is classified as a proteasome inhibitor
Or contact the seller
in section "Oncology Drug Products"
View also products categories "Antineoplastic and immunomodulating medications (L)"